Inspire Medical Systems, Inc.
INSP · NYSE
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | – | $3,829,123 | $4,730,992 | $5,517,465 |
| - Cash | $112,845 | $106,927 | $53,882 | $150,150 |
| + Debt | $30,302 | $33,059 | $33,523 | $31,793 |
| Enterprise Value | – | $3,755,255 | $4,710,633 | $5,399,108 |
| Revenue | $224,501 | $217,086 | $201,317 | $239,718 |
| % Growth | 3.4% | 7.8% | -16% | – |
| Gross Profit | $192,728 | $182,414 | $170,608 | $203,730 |
| % Margin | 85.8% | 84% | 84.7% | 85% |
| EBITDA | $17,228 | $1,086 | $1,559 | $56,754 |
| % Margin | 7.7% | 0.5% | 0.8% | 23.7% |
| Net Income | $9,932 | -$3,592 | $2,992 | $35,224 |
| % Margin | 4.4% | -1.7% | 1.5% | 14.7% |
| EPS Diluted | 0.34 | -0.12 | 0.1 | 1.15 |
| % Growth | 383.3% | -220% | -91.3% | – |
| Operating Cash Flow | $68,526 | $2,684 | -$6,703 | $69,181 |
| Capital Expenditures | -$10,439 | -$8,997 | -$8,407 | -$7,027 |
| Free Cash Flow | $58,087 | -$6,313 | -$15,110 | $62,154 |